Arcus Biosciences Inc (NYSE:RCUS)
$ 16 0.16 (1.01%) Market Cap: 1.46 Bil Enterprise Value: 456.70 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 75/100

Arcus Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 18, 2020 / 02:15PM GMT
Release Date Price: $21.94 (-1.13%)
Zeeshan Merchant;Morgan Stanley;Analyst

Hello, everyone. This is Zeeshan Merchant from Morgan Stanley. This is the fireside chat for Arcus. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

And with that, I'm pleased to be joined today by Arcus. We have both the CEO, Terry Rosen; and President, Juan Jaen.

Questions & Answers

Zeeshan Merchant;Morgan Stanley;Analyst;Terry J. Rosen

And I'll start by beginning questions. Terry, can you please give an overview of Arcus for those that may be new to your story? How would you describe the investment thesis for your company?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot